Health - Greatreporter

ETHIOPIA AND THE NETHERLANDS ENDORSE A GROUNDBREAKING PRIVATE SECTOR WATER MANAGEMENT INITIATIVE TO IMPROVE WATER NEEDS FOR OVER 10 MILLION PEOPLE

March 23, 2023 R Powell

“In a joint press statement today, the Government of the Federal Democratic Republic of Ethiopia and the Kingdom of the Netherlands, along with their partners, endorsed an innovative initiative to implement Water Management through a fully digital approach. This groundbreaking endeavor has the potential to significantly improve the water quality, facilitate direct access, and increase […]

ProMIS Neurosciences Announces Abstracts Accepted for Presentation at the American Academy of Neurology 2023 Annual Meeting

March 13, 2023 R Powell

ProMIS Neurosciences Inc. (TSX: PMN) (Nasdaq: PMN), a biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), today announced an oral presentation and two onsite poster presentations at the upcoming American Academy […]

Promis Neurosciences to Present at the Oppenheimer 33rd Annual Healthcare Conference

March 8, 2023 R Powell

ProMIS Neurosciences Inc. (TSX: PMN) (Nasdaq: PMN), a biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), today announced that Gail Farfel, Ph.D., Chief Executive Officer, will present at the upcoming Oppenheimer […]

World’s Biggest Food Manufacturers Over Reliant on Sales of Unhealthy Foods – New Analysis Reveals

March 3, 2023 R Powell

Four of the world’s biggest food manufacturers are over reliant on the sales of unhealthy food despite each claiming to be active in improving the healthfulness of their products – that’s according to NEW analysis published today by expert research group, World Action on Salt, Sugar & Health (WASSH) and supported by responsible investment NGO, […]

Fobi Signs New PulseIR Deal with Empower Clinics

February 2, 2023 R Powell

Fobi AI Inc. (FOBI:TSXV) (FOBIF:OTCQB) (the “Company” or “Fobi”), an industry leader in harnessing AI and data intelligence to enable digital transformation, is pleased to announce that the company’s wholly-owned subsidiary, PulseIR, has signed a new deal with integrated healthcare provider, Empower Clinics. Empower offers a telemedicine platform for healthcare and diagnostics solutions across the U.S. […]

EVQLV and Libera Bio collaborate to develop and deliver novel antibodies to intracellular cancer targets

January 8, 2023 R Powell

EVQLV Inc. and Libera Bio S.L. have signed a collaboration agreement to jointly address intracellular targets, some of the most elusive cancer targets that represent high unmet medical needs. Antibodies can be designed to address very specific targets along cancer pathways Many of the best-validated intracellular cancer targets have been deemed “undruggable” because large molecules cannot […]

ProMIS Neurosciences Announces Closing of US $7.4 Million Private Placement

October 12, 2022 R Powell

ProMIS Neurosciences Inc. (Nasdaq: PMN) (TSX: PMN), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic misfolded proteins implicated in the development of neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), today announced that it has closed a fully subscribed private placement […]

Grand Opening Massage Therapy Academy, Opens Doors to Meet Demand!

October 7, 2022 R Powell

On October 12, St. Moritz celebrates its grand opening in Centennial, Colorado. St. Moritz plans to operate 100 massage schools across the country and the first location is in the Denver Metro area. Consumers are starting to see it is getting more and more difficult to get a massage due to the high […]

ProMIS Neurosciences appoints accomplished biopharmaceutical leader, Dr. Gail M. Farfel, as Chief Executive Officer

September 13, 2022 R Powell

ProMIS Neurosciences, Inc. (Nasdaq: PMN) (TSX: PMN), a biotechnology company focused on the discovery and development of antibody therapeutics targeting misfolded proteins such as toxic oligomers, implicated in the development of neurodegenerative diseases, announced today that it has appointed Gail M. Farfel, Ph.D., as Chief Executive Officer, effective September 19, 2022. New CEO brings 25 years’ experience […]

ProMIS Neurosciences Presents at 2022 Alzheimer’s Association International Conference

August 2, 2022 R Powell

ProMIS Neurosciences Inc. (Nasdaq: PMN) (TSX: PMN), a biotechnology company focused on the discovery and development of antibody therapeutics targeting misfolded proteins such as toxic oligomers implicated in the development of neurodegenerative diseases, today announced details of its poster presentation at the annual Alzheimer’s Association International Conference (AAIC®) being held from July 31-August 4, 2022 […]